Ripretinib for Gastrointestinal Stromal Tumor User Reviews
Brand names: Qinlock
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about ripretinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
"For me ripretinib (Qinlock) was a total failure. I spent 5 months on this drug and my tumors mostly doubled in size in that time. The side effects were more pronounced and severe including hair loss, fatigue, weight loss than my previous time on Iminatib and Sunitinib. It was easy to use"